A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen
Clinical trial NCT00931463 · COMPLETED
Trial details
- NCT number
- NCT00931463
- Sponsor
- Kirby Institute
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2012-09-01
- Enrollment
- 558
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.